Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
Immunotherapy - the enlisting of the immune system to fight cancer - is an exciting new field that has already led to early trials of new treatments.
Immunotherapy Opens Two Fronts, Innate and Adaptive, against Cancer - Genetic Engineering & Biotechnology News (blog)
GENEVA--(BUSINESS WIRE)--The combination of the investigational cancer immunotherapy Imprime PGG and the monoclonal antibody ...
Professor Mark Cragg, Professor of Experimental Cancer Research at the University of Southampton. Image: University of Southampton.
The second DFCI study, published in the journal Gut, probed that third possibility: that vitamin D boosts theimmune system's anti-cancer function, by ...
Francis Crick Institute scientists, funded by Cancer Research UK, have ... and therapies that harness the body's immune system, at key time points.”.
Over the past decade, cancer treatment has become increasingly sophisticated, harnessing a patient's own immune system to fight tumors, ...
It says unmodified Salmonella would trigger fatal blood poisoning, while over-engineered bacteria would not stimulate the immune system sufficiently ...
A Study Suggests That Salmonella Strains Can Cure Cancer - International Business Times AU
Having battled cancer for years, he knows how important it is to control stress and stay physically and ... We want to support their immune system.
However, inflammation is a complicated process involving many different types of cells from our immune system working together. This has made it ...
Recruiting The Entire Immune System To Attack Cancer. Published: Wednesday, April 15, 2015. Last Updated: Wednesday, April 15, 2015. Bookmark ...
Cancer Sequencing Controls
Comparing a patient’s tumor DNA sequence with that of her normal tissue can improve researchers’ identification of disease-associated mutations.
Cancer Kismet
Fate mapping allows researchers to follow cancer progression from its cell type of origin.
LONDON: An experimental medicine from AstraZeneca that helps the immune system fight tumours has won "orphan" drug status in the United States ...
Seeking a way to stimulate antitumor responses via the immune system, Steven Fiering, PhD, of Norris Cotton Cancer Center at Dartmouth, has ...
A team at Duke University focusing on the immune system found that cells designed to ... The team was also able to block the arginine consumption process using a drug called difluoromethylornithine, which is used to treat cancer.
Hope for Alzheimer's sufferers as scientists claim cancer drug could 'block and reverse' devastating ... -mirror.co.uk
... of cancer-associated antigens together with a potent immune adjuvant called "gp96" to educate and activate a cancer patient's immune system to ...
Newswise — Psychological stress alone does not cause cancer but it can interfere with the immune system'sresponse to cancer cells, which may ...
Study Backs Co-Testing for Cervical Cancer A positive co-test result was more sensitive than either a positive HPV-only test or a positive Pap-only test. Read more
“The factors we found that increase risk of pancreatic cancer now allow us to separate patients as either low or high risk,” says the study's senior ...
Statin Use Inversely Linked to Pancreatic Cancer Risk - Doctors Lounge
Statin use is inversely associated with pancreatic cancer risk, with evidence of a sex-specific risk reduction, according to a study published in Cancer.
Statin Use Linked to Lower Pancreatic CA Risk, But May Be Sex-Specific - Monthly Prescribing Reference
(HealthDay News) -- Using magnetic resonance imaging (MRI) to screen people at high genetic risk for pancreatic cancer might help spot tumors early ...
This technology has generated approximately 10 lead compounds for targeted cancer therapy for pancreatic cancer patients. Our preclinical results ...
After McCall's father passed away from melanoma, and as his youngest brother battled lung and pancreatic cancer, McCall's doctor made a hard pitch ...
But ultimately it is the type of cancer that determines how long and how ... 95.9 per cent for testicular cancer to just 6.8 per cent for pancreatic cancer.
I could have pancreatic cancer," she said. Now, a new surgical device being developed by a team led by Ron Alterovitz, an associate professor at ...
TORRANCE, Calif.--(BUSINESS WIRE)--Celprogen Inc., a leader in the Stem Cell Research and Therapeutics industry for the development of stem ...
Masitinib plus gemcitabine may be effective in the treatment of specific subgroups of patients with advanced pancreatic ductal adenocarcinoma ...
Of those, 84 developed invasive pancreatic cancer. Results showed that all 84 patients had all or some of the following factors: a history of smoking, ...
... arm clinical study examining the use of REOLYSIN® in combination with gemcitabine in patients with advanced pancreatic cancer (REO 017), PD-1 ...
... increased instances in the Haifa Bay area relative to the rest of the country of lung cancer and bladder cancer, both associated with air pollution.
If Patient X were like most people with advanced bladder cancer, she would probably be dead by now. After her first diagnosis, she received standard ...
... with non-small cell lung cancer as well as a Phase 2 trial with its vesigenurtacel-L (HS-410) in patients with non-muscle invasive bladder cancer.
Cancer Network eNewsletter
Too Many DCIS Patients Get Axillary Lymph Node Dissection
No benefit of axillary lymph node evaluation has been shown for women with DCIS, yet this lymph node analysis is still often performed in these patients.
No benefit of axillary lymph node evaluation has been shown for women with DCIS, yet this lymph node analysis is still often performed in these patients.
Cixutumumab Adds No Benefit in ADT-Sensitive Prostate Cancer
Adding cixutumumab to ADT did not significantly increase the undetectable PSA rate in men with newly diagnosed metastatic hormone-sensitive prostate cancer.
Adding cixutumumab to ADT did not significantly increase the undetectable PSA rate in men with newly diagnosed metastatic hormone-sensitive prostate cancer.
Breast Cancer Subtype Associated With Metastasis Pattern, Survival
A recent retrospective study elucidates the correlation between breast cancer subtype and metastasis site, time to relapse, and patient survival.
A recent retrospective study elucidates the correlation between breast cancer subtype and metastasis site, time to relapse, and patient survival.
Urinary Markers May Predict Response to Re-irradiation of Bone Metastases
In a recently published study, patients who did not respond to initial radiation or re-irradiation of symptomatic bone metastases had significantly higher urinary markers of bone turnover at baseline and follow-up.
In a recently published study, patients who did not respond to initial radiation or re-irradiation of symptomatic bone metastases had significantly higher urinary markers of bone turnover at baseline and follow-up.
Science Daily Cancer News
Cancer mortality remains significantly elevated among African-Americans. Between 2000 and 2010, overall mortality from cancer decreased faster among African-American women and men than among Caucasians. If current trends continue, racial disparities in cancer outcomes are expected to narrow further and might disappear over time.
Investigators tried to validate a previously reported molecular finding on triple negative breast cancer that many hoped would lead to targeted treatments for the aggressive disease. Instead, they discovered that the findings were limited to a single patient and could not be applied to further clinical work. This discovery amends the earlier work and underscores the importance of independent study validation and careful assay development.
45 core competency statements have been finalized for oncology patient navigators. These competency statements were created through literature review, focus group data analysis, expert review, and a national survey of oncology patient navigation stakeholders.
A common anti-fungal treatment has joined the ranks of drugs that may be suitable for use in treating cancer, according to research from the Repurposing Drugs in Oncology (ReDO) project. The ReDO project is an international collaboration of anticancer researchers dedicated to promoting the cause of common medicines which may represent an untapped source of novel therapies for cancer. Itraconazole is a drug used to treat a broad range of fungal infections, including skin and nail infections. It also has a lot of potential as a new cancer treatment, according to the ReDo project.
For the first time, researchers have linked a new protein with malignant melanomas. The protein is detected in aggressive malignant melanoma cells and might be used to predict whether and how the cancer will spread. At the same time, the discovery also opens new doors for future improved treatment of patients with melanomas.
By analyzing a simple blood sample, scientists have succeeded in predicting if a woman will get breast cancer within two to five years. The method -- a metabolic blood profile -- is still in the early stages but over time the scientists expect it could be used to predict breast cancer and more generally to predict chronic disease.
Recent media attention has focused on American actress Angelina Jolie's decision to have her ovaries and fallopian tubes surgically removed after genetic testing for such cancers. A study suggests that all women with ovarian cancer should be tested for these genes, regardless of their family history. The findings have clinical implications both for the treatment of this disease and for the screening of individuals at-risk.
Scientists have identified a way to potentially predict which patients with an early form of breast cancer will experience disease progression. Ductal carcinoma in situ (DCIS) is a precursor of breast cancer where the cancerous cells are contained within the milk-making ducts. Without treatment, commonly a combination of breast-conserving surgery and radiotherapy, up to a half of patients will have their disease come back, either as DCIS or as invasive breast cancer.
Tambahkan Komentar